Coeliac disease serology

Targeting coeliac disease serology

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8120 (Published 10 December 2012)
Cite this as: BMJ 2012;345:e8120

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David J Unsworth, consultant immunologist1,
  2. Francis J Smith, biomedical scientist2,
  3. Robert J Lock, consultant clinical scientist1
  1. 1Department of Immunology and Immunogenetics, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK
  2. 2Department of Immunology, Gloucester Royal Hospital, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
  1. joe.unsworth{at}nbt.nhs.uk

We agree that testing first degree relatives of patients with coeliac disease (CD) for gluten enteropathy is worthwhile but caution against less targeted testing, especially in patients with non-specific symptoms.1

The prevalence of CD in England is estimated at 1.0-1.2%.2 3 Prevalence is higher in “at risk” groups: 5-6% in first degree relatives and 6% in people with type …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL